GWSG
LENZ

GPS Wealth Strategies Group’s LENZ Therapeutics LENZ Stock Holding History

GPS Wealth Strategies Group’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.86K Hold
179
– – ﹤0.01% 515
2025
Q3 		$8.34K Hold
179
– – ﹤0.01% 1135
2025
Q2 		$5.25K Buy
+179
New +$4.87K ﹤0.01% 1187

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

GPS Wealth Strategies Group's LENZ Position: Q4 2025 in Review

GPS Wealth Strategies Group held its LENZ Therapeutics (LENZ) position steady in Q4 2025 at 179 shares worth $2.86K. The position accounts for ﹤0.01% of the portfolio, ranked #515.

GPS Wealth Strategies Group first reported a position in LENZ in Q2 2025 and has held it in 3 quarters since. The position peaked at $8.34K in Q3 2025. 160 funds tracked by Wall St. Rank hold LENZ as of Q4 2025.

  • GPS Wealth Strategies Group held 179 shares of LENZ Therapeutics worth $2.86K as of Q4 2025.
  • GPS Wealth Strategies Group left its LENZ Therapeutics share count unchanged in Q4 2025.
  • LENZ Therapeutics made up ﹤0.01% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #515 holding.
  • GPS Wealth Strategies Group first reported a position in LENZ Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • GPS Wealth Strategies Group's LENZ Therapeutics position peaked at $8.34K in Q3 2025.
  • 160 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.